▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2536 by analyst upside · 2026-09-27
TFX
Teleflex Incorporated
Healthcare · Market Cap $5B · P/E 0x
ANALYST PRICE TARGET
+25.8%
implied upside to consensus target
Current Price $122.07
Consensus Target $153.55
Bull Target $170.0
Bear Target $138.0
Analysts Covering 11
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
1
Hold
7
Sell
0
52-Week Low $100.18
52-Week High $145.0
YTD Return +0.5%
FUNDAMENTALS
Market Cap $5B
P/E Ratio (TTM) N/A
Forward P/E 11.1x
EPS (TTM) $-0.52
PEG Ratio 0.16
Dividend Yield 1.11%
Revenue (TTM) $2.3B
Profit Margin -45.8%
52-WEEK RANGE
52-Week Low $100.18
52-Week High $145.0
Current Price $122.07
Bear Target $138.0
Bull Target $170.0
● Now $122.07 ● Target $153.55
TRADING DATA
Avg Volume 602K
YTD Return +0.5%
Analyst Count 11
Consensus Buy
Upside to Target +25.8%
Last Updated 2026-09-27

ANALYST SUMMARY

Teleflex Incorporated (TFX) is currently trading at $122.07 with a Wall Street consensus price target of $153.55, implying potential upside of 25.8% over the next 12 months. 11 analysts currently cover TFX, with a consensus rating of Buy - 36% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $170.0, while the most cautious has a target of $138.0.

TFX operates in the Healthcare sector with a market capitalisation of $5B. The stock is up 0.5% year-to-date and is currently trading near the lower end of its 52-week range of $100.18 – $145.0.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for TFX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Needham - Reiterated
Buy → Buy 2026-08-25 20% win rate (5 calls)
UBS - Reiterated
Neutral → Neutral 2026-08-11 33% win rate (6 calls)
Truist Securities - Reiterated
Hold → Hold 2026-08-10 Building track record
Piper Sandler reit
Overweight → Overweight 2026-08-07 14% win rate (7 calls)
Needham - Reiterated
Buy → Buy 2026-07-31 20% win rate (5 calls)
UBS ● Initiated
Neutral 2026-07-28 33% win rate (6 calls)
Mizuho - Reiterated
Neutral → Neutral 2026-07-15 Building track record
BMO Capital ● Initiated
Outperform 2026-07-09 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
46
out of 100
Coverage depth
19/30
Consensus clarity
25/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →